In osteoarthritis, icariin inhibits ferroptosis through the Nrf2/System Xc−/GPX4 axis and alleviates synoviocyte damage,165 suggesting that icariin can be exploited as a novel therapeutic candidate for synovitis. Here, GPX4 is linked to osteoarthritis.